Literature DB >> 17618535

Depression and apathy in Parkinson's disease.

Irene Hegeman Richard1.   

Abstract

This article provides an update on depression and apathy in Parkinson's disease (PD), both of which are common but often misunderstood. The diagnosis of depression in PD can be challenging and we still do not have solid evidence on which to base our treatment decisions. Apathy is most commonly seen in the setting of dementia or depression but emerging evidence suggests that it may be a core feature of PD. There are conflicting reports about the effects of deep brain stimulation (DBS) on mood and apathy, but studies suggest that at least some patients may develop depression and apathy after the procedure. Although we are making strides toward a better understanding of depression and apathy in PD, it is clear that more research is needed about these non-motor features.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618535     DOI: 10.1007/s11910-007-0045-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  37 in total

1.  Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.

Authors:  Angelo Antonini; Silvana Tesei; Anna Zecchinelli; Paolo Barone; Danilo De Gaspari; Margherita Canesi; Giorgio Sacilotto; Nicoletta Meucci; Claudio Mariani; Gianni Pezzoli
Journal:  Mov Disord       Date:  2006-08       Impact factor: 10.338

2.  Validity of the 30-item geriatric depression scale in patients with Parkinson's disease.

Authors:  William M McDonald; Paul E Holtzheimer; Michael Haber; Jerrold L Vitek; Kimberly McWhorter; Mahlon Delong
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

Review 3.  Deep brain stimulation: neuropsychological and neuropsychiatric issues.

Authors:  Valerie Voon; Cynthia Kubu; Paul Krack; Jean-Luc Houeto; Alexander I Tröster
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

4.  Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.

Authors:  Matthias R Lemke; H Michael Brecht; Juergen Koester; Heinz Reichmann
Journal:  J Neurol Sci       Date:  2006-06-30       Impact factor: 3.181

5.  Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.

Authors:  L Castelli; P Perozzo; M Zibetti; B Crivelli; U Morabito; M Lanotte; F Cossa; B Bergamasco; L Lopiano
Journal:  Eur Neurol       Date:  2006-05-08       Impact factor: 1.710

6.  Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

Authors:  R Mössner; A Henneberg; A Schmitt; Y V Syagailo; M Grässle; T Hennig; R Simantov; M Gerlach; P Riederer; K P Lesch
Journal:  Mol Psychiatry       Date:  2001-05       Impact factor: 15.992

7.  Dissociating apathy and depression in Parkinson disease.

Authors:  L Kirsch-Darrow; H H Fernandez; H F Fernandez; M Marsiske; M S Okun; D Bowers
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

8.  Reliability and validity of the Beck depression inventory in patients with Parkinson's disease.

Authors:  Martine Visser; Albert F G Leentjens; Johan Marinus; Anne M Stiggelbout; Jacobus J van Hilten
Journal:  Mov Disord       Date:  2006-05       Impact factor: 10.338

9.  The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.

Authors:  P Sockeel; K Dujardin; D Devos; C Denève; A Destée; L Defebvre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

10.  Evidence for atypical depression in Parkinson's disease.

Authors:  R B Schiffer; R Kurlan; A Rubin; S Boer
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  6 in total

Review 1.  Stress, depression and Parkinson's disease.

Authors:  Ann M Hemmerle; James P Herman; Kim B Seroogy
Journal:  Exp Neurol       Date:  2011-10-06       Impact factor: 5.330

2.  Orthopedic Surgery and Post-Operative Cognitive Decline in Idiopathic Parkinson's Disease: Considerations from a Pilot Study.

Authors:  Catherine C Price; Shellie-Anne Levy; Jared Tanner; Cyndi Garvan; Jade Ward; Farheen Akbar; Dawn Bowers; Mark Rice; Michael Okun
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

3.  Subthalamic nucleus stimulation in Parkinson's disease.

Authors:  Roberto Marconi; Andrea Landi; Franco Valzania
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

4.  Computational investigation of the impact of deep brain stimulation contact size and shape on neural selectivity.

Authors:  Daria Nesterovich Anderson; Alan D Dorval; John D Rolston; Stefan M Pulst; Collin J Anderson
Journal:  J Neural Eng       Date:  2021-04-06       Impact factor: 5.379

5.  The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD.

Authors:  Irene Hegeman Richard; Kori A LaDonna; Rosanne Hartman; Carol Podgorski; Roger Kurlan
Journal:  Neuropsychiatr Dis Treat       Date:  2007-12       Impact factor: 2.570

6.  Relationships between activity and well-being in people with parkinson's disease.

Authors:  Felicitas Ehlen; Katharina Schindlbeck; Lisa Nobis; André Maier; Fabian Klostermann
Journal:  Brain Behav       Date:  2018-04-16       Impact factor: 2.708

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.